does semaglutide help with hot flashes Ozempic and Flushes: Causes, Management, and When to Seek In this study, women who

Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently under clinical investigation and not yet approved by the MHRA or EMA

While our study included only women treated within the year before documented fertility-related events, we could not confirm adherence to this washout period, and it remains possible that physiological or residual pharmacologic effects persisted, influencing outcomes

Among semaglutide participants, 86.4% achieved at least 5% weight loss, 69.1% achieved 10% or more, and 50.5% achieved 15% or more

4,38,39 Interestingly, several studies have demonstrated positive results for MS management through physical activity, emphasizing exercise as a form of medicine

Mitochondria-associated membranes in aging and senescence: structure, function, and dynamics